Harmony Biosciences Holdings (HRMY) Tax Provisions (2021 - 2026)

Harmony Biosciences Holdings has disclosed Tax Provisions across 6 years of filings, most recently posting $7.2 million for Q1 2026.

• Tax Provisions for Q1 2026 came in at $7.2 million, down 38.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.3 million (up 148.67% YoY), and the FY2025 annual result was $41.7 million, up 147.83% from the prior year.
• Tax Provisions came in at $7.2 million for Q1 2026 at Harmony Biosciences Holdings, up from $3.6 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $81.5 million in Q4 2022 to a low of -$80.0 million in Q3 2022.
• The 5-year median for Tax Provisions is $9.9 million (2025), against an average of $7.0 million.
• Peak annual rise in Tax Provisions reached 1405.21% in 2022, while the deepest fall reached 8766.52% in 2022.
• Harmony Biosciences Holdings' Tax Provisions stood at $81.5 million in 2022, then sank by 83.96% to $13.1 million in 2023, then tumbled by 274.17% to -$22.8 million in 2024, then jumped by 116.0% to $3.6 million in 2025, then soared by 97.45% to $7.2 million in 2026.
• The last three Tax Provisions figures came in at $7.2 million (Q1 2026), $3.6 million (Q4 2025), and $16.6 million (Q3 2025), per Business Quant data.